Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Taylor

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Age and Ageing|November 13, 2023
New horizons in evidence synthesis for older adultsNicola Cooper, Evi Germeni, Suzanne C Freeman, et al.
International Journal of Geriatric Psychiatry|March 12, 2022
Comparative validity of informant tools for assessing pre-stroke cognitive impairmentMartin Taylor-Rowan, Lucy McGuire, Melanie Hafdi, et al.
The Journal of Animal Ecology|September 3, 2025
Limited inbreeding avoidance at the gamete level despite inbreeding depression in Atlantic salmon (Salmo salar)Marco Graziano, Monica Solberg, Kevin A Glover, et al.
Journal of the American Medical Directors Association|July 26, 2020
Anticholinergic Burden Measures Predict Older People's Physical Function and Quality of Life: A Systematic ReviewCarrie Stewart, Kaisa Yrjana, Mitrysha Kishor, et al.
Health Open Research|May 6, 2024
Protocol for the development and validation of a patient reported measure (PRM) of treatment burden in strokeKatie I Gallacher, Martin Taylor-Rowan, David T Eton, et al.
The Cochrane Database of Systematic Reviews|June 7, 2021
Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndromeMartin Taylor-Rowan, Sophie Edwards, Anna H Noel-Storr, et al.
Journal of Clinical Pathology|April 9, 2022
Overexpression of integrin alpha 2 (ITGA2) correlates with poor survival in patients with pancreatic ductal adenocarcinomaSteffen Deichmann, Leif Schindel, Rüdiger Braun, et al.
Stroke|May 29, 2025
Validation and Feasibility of PETS-Stroke: A Patient-Reported Measure of Treatment Burden After StrokeMartin Taylor-Rowan, David T Eton, Hamish J McLeod, et al.
Health Technology Assessment (Winchester, England)|December 6, 2025
Risk assessment tools for predicting transfusion in surgery: a systematic review and meta-analysisAbril Seyahian, Martin Taylor-Rowan, Clareece Nevill, et al.
Iscience|September 13, 2022
Cyclophosphamide depletes tumor infiltrating T regulatory cells and combined with anti-PD-1 therapy improves survival in murine neuroblastomaEmily R Webb, Julia Moreno-Vincente, Alistair Easton, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Age and Ageing|November 13, 2023
New horizons in evidence synthesis for older adultsNicola Cooper, Evi Germeni, Suzanne C Freeman, et al.
International Journal of Geriatric Psychiatry|March 12, 2022
Comparative validity of informant tools for assessing pre-stroke cognitive impairmentMartin Taylor-Rowan, Lucy McGuire, Melanie Hafdi, et al.
The Journal of Animal Ecology|September 3, 2025
Limited inbreeding avoidance at the gamete level despite inbreeding depression in Atlantic salmon (Salmo salar)Marco Graziano, Monica Solberg, Kevin A Glover, et al.
Journal of the American Medical Directors Association|July 26, 2020
Anticholinergic Burden Measures Predict Older People's Physical Function and Quality of Life: A Systematic ReviewCarrie Stewart, Kaisa Yrjana, Mitrysha Kishor, et al.
Health Open Research|May 6, 2024
Protocol for the development and validation of a patient reported measure (PRM) of treatment burden in strokeKatie I Gallacher, Martin Taylor-Rowan, David T Eton, et al.
The Cochrane Database of Systematic Reviews|June 7, 2021
Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndromeMartin Taylor-Rowan, Sophie Edwards, Anna H Noel-Storr, et al.
Journal of Clinical Pathology|April 9, 2022
Overexpression of integrin alpha 2 (ITGA2) correlates with poor survival in patients with pancreatic ductal adenocarcinomaSteffen Deichmann, Leif Schindel, Rüdiger Braun, et al.
Stroke|May 29, 2025
Validation and Feasibility of PETS-Stroke: A Patient-Reported Measure of Treatment Burden After StrokeMartin Taylor-Rowan, David T Eton, Hamish J McLeod, et al.
Health Technology Assessment (Winchester, England)|December 6, 2025
Risk assessment tools for predicting transfusion in surgery: a systematic review and meta-analysisAbril Seyahian, Martin Taylor-Rowan, Clareece Nevill, et al.
Iscience|September 13, 2022
Cyclophosphamide depletes tumor infiltrating T regulatory cells and combined with anti-PD-1 therapy improves survival in murine neuroblastomaEmily R Webb, Julia Moreno-Vincente, Alistair Easton, et al.
Pageof 9